Company intelligence / Profile preview

Laboratorio Libra

Montevideo, Montevideo Department, Uruguaylablibra.com ↗

Ownership: Private
Employees: ~102
Development stage: Commercial

Overview

Laboratorio Libra has over fifty years of experience producing and exporting pharmaceutical products. The company operates internationally with a focus on Latin America and has established partnerships for the exclusive marketing of CNS drugs in Chile. It maintains a strong commitment to quality and environmental responsibility.

Therapeutic areas: OtherPsychiatryRheumatologyNeurologyInfectious Diseases
Modalities: Small molecules
Industry: Biotech

Drug pipeline

3 assets

lenalidomide

Commercial

Indications: Oncology

2 more assets in the full pipeline.

Request access →

Partnerships

Luye Pharma Group – exclusive marketing rights for Seroquel/Seroquel XR in Chile

Beyond the preview

Go deeper on Laboratorio Libra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratorio Libra.

Explore the full profile